基于多参数磁共振成像对前列腺PI-RADS-3不确定病变进行亚分类以提高癌症检出
该研究纳入143例MRI上为PI-RADS 3索引病变的患者,行靶向经会阴MR/US融合活检,两位放射科医生(2年和7年经验)盲法回顾性二次阅片并按预设标准给出活检建议。结果显示,外周带病变的形状和ADC、移行带病变的位置、边界和ADC与癌症检出相关,有经验医生的活检建议可提高预测价值。
要点
- 外周带PI-RADS 3病变中,圆形者癌检出率0.69±0.23,高于地理样者0.26±0.13(p=0.0055)。
- 移行带PI-RADS 3病变中,前部者癌检出率0.63±0.15,高于中部/后部者0.31±0.14(p=0.0048)。
- 有经验医生建议活检的PPV为0.61±0.11,高于不建议活检的0.21±0.10(p=0.0001)。
核心结论
- 识别特定的客观影像标准以及有经验放射科医生的主观活检建议,可帮助提高不确定前列腺病变的预测价值,并为是否活检的决策提供信息。
研究设计与样本
- 回顾性研究,纳入143例MRI上为PI-RADS 3索引病变并接受靶向经会阴MR/US融合活检的患者;两位分别有2年和7年经验的放射科医生进行盲法回顾性二次阅片,使用预设标准并给出活检建议。
关键影像表现/征象
- 外周带病变:圆形者任何癌检出率0.69±0.23,地理样者0.26±0.13(p=0.0055)。
- 外周带病变:ADC明显受限者任何癌检出率0.81±0.19,轻度受限者0.21±0.12(p=0.0001)。
- 移行带病变:前部者任何癌检出率0.63±0.15,中部/后部者0.31±0.14(p=0.0048)。
- 移行带病变:边界不清者任何癌检出率0.61±0.15,假包膜者0.32±0.14(p=0.0092)。
- 移行带病变:ADC明显受限者任何癌检出率0.68±0.17,轻度受限者0.35±0.12(p=0.0057)。
诊断标准与关键数值
- 总体活检结果:43%(61/143)患者为Gleason评分6-10,21%(30/143)为Gleason评分≥3+4。
- 有经验阅片者建议活检的任何癌PPV为0.61±0.11,不建议活检者为0.21±0.10(p=0.0001)。
- 有经验阅片者建议活检的Gleason评分7-10癌PPV为0.32±0.10,不建议活检者为0.08±0.07(p=0.0003)。
- 活检建议的阅片者间一致性为62%(89/143)。
临床应用与阅片要点
- 对于PI-RADS 3病变,可结合外周带形状(圆形vs地理样)和ADC受限程度、移行带位置(前部vs中部/后部)、边界(假包膜vs边界不清)及ADC受限程度进行亚分类。
- 有经验放射科医生基于上述标准给出的活检建议可能有助于提高不确定前列腺病变的预测价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate sub-differentiation of PI-RADS-3 prostate lesions using pre-defined T2- and diffusion-weighted (DWI) MRI criteria, to aid the biopsy decision process.
METHODS: 143 patients with PIRADS-3 index lesions on MRI underwent targeted transperineal-MR/US fusion biopsy. Radiologists with 2 and 7-years experience performed blinded retrospective second-reads using set criteria and assigned biopsy recommendations. Inter-reader agreement, Gleason score (GS), positive (PPV) predictive values (±95% confidence intervals) were calculated and compared by Fisher's exact test with Bonferroni-Hom correction.
RESULTS: 43% (61/143) patients had GS 6-10 and 21% (30/143) GS≥3+4 cancer. For peripheral zone lesions, significant differences in any cancer detection were found for shape (0.26±0.13 geographical vs. 0.69±0.23 rounded; p=0.0055) and ADC (mild 0.21±0.12 vs marked 0.81±0.19; p=0.0001). For transition zone, significantly increased cancer detection was shown for location (anterior 0.63±0.15 vs. mid/posterior 0.31±0.14; p=0.0048), border (pseudo-capsule 0.32±0.14 vs. ill-defined 0.61±0.15; p=0.0092), and ADC (mild 0.35±0.12 vs marked restriction 0.68±0.17; p=0.0057). Biopsy recommendations had 62% inter-reader agreement (89/143). Experienced reader PPVs were significantly higher for any cancer with "biopsy-recommended" 0.61±0.11 vs. "no biopsy" 0.21±0.10 (p=0.0001), and for GS 7-10 cancers: 0.32±0.10 vs. 0.08±0.07, respectively (p=0.0003).
CONCLUSION: Identification of certain objective imaging criteria as well as a subjective biopsy recommendation from an experienced radiologist can help to increase the predictive value of equivocal prostate lesions and inform the decision making process of whether or not to biopsy.
引用
- Hansen NL, Koo BC, Warren AY, et al. Sub-differentiating equivocal PI-RADS-3 lesions in multiparametric magnetic resonance imaging of the prostate to improve cancer detection. Eur J Radiol. 2017. PMID: 28987685. doi:10.1016/j.ejrad.2017.08.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。